Brainstem

Introduction

Brainstem is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. ^{1NCBI Bookshelf2024Open reference}

The brainstem is the posterior part of the brain that connects the cerebrum to the spinal cord and cerebellum. Composed of three main divisions—the midbrain (mesencephalon), pons (metencephalon), and medulla oblongata (myelencephalon)—the brainstem controls vital autonomic functions including respiration, cardiovascular regulation, and consciousness. It houses the nuclei of cranial nerves III–XII and serves as a critical relay station for ascending and descending neural pathways. The brainstem is profoundly affected in multiple neurodegenerative diseases, including ALS, Multiple System Atrophy, Progressive Supranuclear Palsy, and Parkinson’s disease. ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}

Overview

The brainstem represents the evolutionary oldest portion of the brain and is essential for survival. It integrates sensory and motor information between the cerebral cortex and the spinal cord, regulates the sleep-wake cycle, and controls the autonomic nervous system. In neurodegenerative diseases, brainstem pathology can produce devastating symptoms including dysphagia, dysarthria, respiratory failure, autonomic dysfunction, and disturbances of eye movement and balance^[1]. ^{3*The Human Brainstem: Anatomy and Pathology*2022 · The Human Brainstem: Anatomy and PathologyOpen reference}

Understanding brainstem anatomy and its vulnerability to neurodegeneration is critical for diagnosing and managing conditions such as PSP (characterized by midbrain atrophy), MSA (with pontine and olivary degeneration), and ALS (with motor neuron loss in the medulla). ^{4The substantia nigra of the human brain1999 · Brain · PMID 12439901Open reference}

Anatomy and Organization

Midbrain (Mesencephalon)

The midbrain is the most rostral division of the brainstem, situated between the diencephalon above and the pons below. Key structures include: ^{5Long road to ruin: noradrenergic dysfunction in neurodegenerative disease2018 · Trends Neurosci · PMID 28602550Open reference}

• Substantia nigra: Contains dopaminergic neurons of the pars compacta (SNc) that project to the striatum, forming the nigrostriatal pathway. Degeneration of these neurons is the hallmark of Parkinson’s disease.

• Red nucleus: Involved in motor coordination and receives input from the cerebellum and cerebral cortex.

• Superior and inferior colliculi: The tectum processes visual (superior) and auditory (inferior) reflexes.

• Periaqueductal gray (PAG): Plays a role in pain modulation, defensive behaviors, and autonomic regulation.

• Cerebral peduncles: Contain descending corticospinal and corticobulbar tracts.

• Cranial nerve nuclei: Oculomotor (III) and trochlear (IV) nuclei controlling eye movements^[2].

Pons (Metencephalon)

The pons is the middle division of the brainstem, situated between the midbrain and medulla. It serves as a major relay between the cerebral cortex and cerebellum: ^{6Staging of brain pathology related to sporadic Parkinson's Disease2003 · Neurobiol Aging · PMID 12498954Open reference}

• Pontine nuclei: Receive cortical input and relay it to the cerebellum via the middle cerebellar peduncles.

• Locus coeruleus: The primary source of norepinephrine in the brain, located in the dorsal pons. Early degeneration of this nucleus occurs in Alzheimer’s and Parkinson’s disease.

• Raphe nuclei (dorsal and median): A major source of serotonin projecting widely throughout the brain.

• Reticular formation: Contributes to the ascending reticular activating system (ARAS) that maintains wakefulness and arousal.

• Cranial nerve nuclei: Trigeminal (V), abducens (VI), facial (VII), and vestibulocochlear (VIII)^[2].

Medulla Oblongata (Myelencephalon)

The medulla is the most caudal division of the brainstem, continuous with the spinal cord at the foramen magnum: ^{7Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats2014 · Acta Neuropathol · PMID 25614368Open reference}

• Cardiovascular center: Regulates heart rate and blood pressure through sympathetic and parasympathetic outflow.

• Respiratory center: The dorsal and ventral respiratory groups control breathing rhythm.

• Inferior olivary nucleus: Relays information to the cerebellum for motor learning and coordination.

• Nucleus tractus solitarius (NTS): Receives visceral sensory information from the vagus nerve; critical for autonomic regulation.

• Dorsal motor nucleus of the vagus (DMV): Controls parasympathetic output to thoracic and abdominal organs. Among the earliest sites of alpha-synuclein pathology in parkinsons^[6].

• Area postrema: A circumventricular organ involved in the vomiting reflex and immune-to-brain signaling.

• Cranial nerve nuclei: Glossopharyngeal (IX), vagus (X), accessory (XI), and hypoglossal (XII)^[2].

Neurotransmitter Systems

The brainstem contains the cell bodies of the major modulatory neurotransmitter systems that project widely throughout the central nervous system: ^{8Oxford Academic2025Open reference}

| Neurotransmitter | Brainstem Source | Target Regions | Disease Relevance | ^{9Tauopathies2017 · Handb Clin Neurol · PMID 28608325Open reference} |-----------------|-----------------|----------------|-------------------| ^{10Journal of Neurology2025Open reference} | dopamine | substantia nigra, ventral tegmental area | striatum, prefrontal cortex, limbic system | Parkinson’s, MSA | ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}0 | norepinephrine | locus coeruleus | Widespread cortical and subcortical | Alzheimer’s, PSP | ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}1 | serotonin | Raphe nuclei | Widespread cortical and subcortical | MSA, depression in PD | ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}2 | acetylcholine | Pedunculopontine nucleus, laterodorsal tegmental nucleus | thalamus, basal ganglia | PSP, Lewy body dementia | ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}3

These neuromodulatory systems are frequently and often early targets of neurodegenerative pathology, contributing to the diverse non-motor symptoms seen in these diseases^[5]. ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}4

Role in Neurodegenerative Diseases

Parkinson’s Disease

Braak staging of Parkinson’s disease pathology identifies the brainstem as the initial site of alpha-synuclein accumulation. In Braak stages 1–2, Lewy body pathology begins in the dorsal motor nucleus of the vagus and the olfactory bulb before ascending to the locus coeruleus and ultimately the substantia nigra in stages 3–4. This caudal-to-rostral spread supports the hypothesis that PD may begin in the peripheral autonomic nervous system and propagate to the brainstem via the vagus nerve. ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}5

Brainstem involvement in parkinsons produces: ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}6

• Motor symptoms: Bradykinesia, rigidity, tremor (due to substantia-nigra degeneration)

• Sleep disturbances: REM sleep behavior disorder (due to sublaterodorsal nucleus and pedunculopontine nucleus dysfunction)

• Autonomic dysfunction: Orthostatic hypotension, constipation (due to DMV and medullary autonomic nuclei involvement)

• Dysphagia: Difficulty swallowing (due to medullary motor nuclei degeneration)

Progressive Supranuclear Palsy (PSP)

PSP is a 4-repeat tauopathy with prominent brainstem pathology. The midbrain is disproportionately affected, producing the characteristic “hummingbird sign” on MRI (midbrain atrophy with preserved pons). Key brainstem features include:

• Vertical supranuclear gaze palsy: Due to degeneration of the rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF) and the interstitial nucleus of Cajal

• Postural instability: Related to pedunculopontine nucleus degeneration

• Pseudobulbar palsy: From corticobulbar tract and brainstem motor nuclei involvement

• Tau pathology: Neurofibrillary tangles and tufted astrocytes in midbrain, pons, and dentate nucleus.

Recent DTI studies have revealed impairment of the glymphatic system throughout the brainstem in PSP, suggesting that clearance dysfunction may contribute to tau accumulation. ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}7

Multiple System Atrophy (MSA)

MSA is an alpha-synuclein-driven disease characterized by glial cytoplasmic inclusions (GCIs) in oligodendrocytes. The brainstem is extensively affected in both subtypes:

• MSA-P (parkinsonian): Predominant striatonigral degeneration with substantia nigra and striatal pathology

• MSA-C (cerebellar): Olivopontocerebellar atrophy with loss of pontine nuclei, inferior olivary neurons, and cerebellar Purkinje cells

• Autonomic failure: Due to degeneration of the dorsal motor nucleus of the vagus, nucleus tractus solitarius, and ventrolateral medullary catecholaminergic neurons

• “Hot cross bun sign”: Cruciform hyperintensity on pontine MRI caused by selective loss of pontine neurons and myelinated transverse fibers with preservation of the pontine tegmentum and raphe nuclei.

Recent 2026 research has identified significant serotoninergic neuronal loss in the brainstem raphe nuclei in MSA, which may contribute to sudden death in these patients. ^{2Cranial Nerves2016 · A Textbook of Neuroanatomy · PMID 30725827Open reference}8

Amyotrophic Lateral Sclerosis (ALS)

In als, degeneration of motor neurons in the brainstem produces bulbar symptoms:

• Bulbar-onset ALS: Begins with dysarthria and dysphagia due to degeneration of hypoglossal (XII), vagal (X), and facial (VII) motor nuclei

• Pseudobulbar affect: Emotional lability from corticobulbar tract degeneration

• Respiratory failure: Progressive involvement of respiratory motor neurons in the medulla and phrenic nerve nucleus

• tdp-43 pathology: Cytoplasmic inclusions in brainstem motor neurons and associated glial cells^[13].

Alzheimer’s Disease

While alzheimers primarily affects cortical and hippocampal regions, brainstem nuclei are also impacted:

• locus-coeruleus: Among the earliest sites of tau pathology in alzheimers, preceding cortical neurofibrillary tangles. Loss of noradrenergic neurons contributes to attention deficits and may accelerate neuroinflammation^[5].

• Raphe nuclei: Serotonergic neuron loss contributes to depression and sleep disturbances in AD

• nucleus-basalis-of-meynert: Though technically basal forebrain, cholinergic loss in this region connects to brainstem cholinergic nuclei disruption^[14].

Prion Diseases

prion-diseases such as creutzfeldt-jakob can involve the brainstem extensively, producing myoclonus, ataxia, and autonomic dysfunction. Spongiform changes, gliosis, and prion-protein deposition are found throughout the brainstem nuclei^[15].

Diagnostic Imaging

Brainstem imaging plays a crucial role in diagnosing neurodegenerative diseases:

• MRI volumetry: Midbrain-to-pons ratio distinguishes PSP from other parkinsonian syndromes. The midbrain area/pons area ratio (M/P ratio) is significantly reduced in PSP^[8].

• Diffusion tensor imaging (DTI): Reveals microstructural white matter changes in brainstem tracts before visible atrophy occurs^[11].

• DAT-SPECT: DaTSCAN imaging shows reduced dopamine transporter binding in the striatum reflecting nigrostriatal degeneration.

• Transcranial sonography: Hyperechogenicity of the substantia nigra is a biomarker for Parkinson’s Disease.

• 7T MRI: Ultra-high-field MRI enables visualization of individual brainstem nuclei including the locus-coeruleus, raphe nuclei, and substantia nigra subregions^[16].

Therapeutic Targets

The brainstem’s involvement in neurodegenerative diseases creates both challenges and opportunities for therapeutic intervention:

• deep-brain-stimulation: The pedunculopontine nucleus (PPN) is a DBS target for gait freezing in Parkinson’s Disease and PSP^[17].

• Vagus nerve stimulation: Non-invasive vagus nerve stimulation is being explored for neuroprotection and anti-inflammatory effects via the cholinergic anti-inflammatory pathway.

• Noradrenergic therapies: Pharmacological restoration of norepinephrine signaling via atomoxetine or droxidopa aims to compensate for locus-coeruleus degeneration^[5].

• gene-therapy: Viral vector delivery of neurotrophic factors (e.g., gdnf, neurturin) to brainstem nuclei is under investigation for Parkinson’s Disease.

• substantia-nigra — Midbrain structure in brainstem

• thalamus — Diencephalic relay connected to brainstem

• parkinsons — Disease with brainstem pathology

• als — Disease affecting brainstem motor neurons

• locus-coeruleus — Brainstem noradrenergic nucleus

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data

Brain Atlas Resources

The brainstem is extensively characterized in multiple Allen Institute atlas resources, providing valuable gene expression and cell type data for neurodegeneration research:

• Allen Human Brain Atlas: The comprehensive atlas includes detailed gene expression data for all brainstem regions. Researchers can explore region-specific expression patterns for the midbrain, pons, and medulla through the Brainstem expression search. Single-nucleus RNA-seq data from the brainstem enables identification of cell type-specific molecular changes in neurodegenerative diseases^[18].

• Allen Mouse Brain Atlas: The mouse brainstem is comprehensively mapped with detailed anatomical annotations. The Brainstem search provides access to ISH gene expression data across development and adulthood. Mouse models of neurodegeneration often focus on brainstem nuclei (e.g., locus coeruleus, substantia nigra) making this resource essential for cross-species comparisons^[19].

• Allen Cell Type Atlas: Single-cell transcriptomic profiling of brainstem cell types is available through the Transcriptomic cell type reference. Key cell types profiled include dopaminergic neurons of the substantia nigra, noradrenergic neurons of the locus coeruleus, serotonergic neurons of the raphe nuclei, and various glial cell types. This atlas enables molecular characterization of cell types vulnerable in Parkinson’s Disease, MSA, and other brainstem-affecting disorders^[20].

• BrainSpan Developmental Transcriptome: The developmental atlas provides temporal gene expression data for the brainstem across prenatal and postnatal development. The Brainstem developmental expression dataset reveals genes with stage-specific expression patterns that may inform understanding of developmental vulnerabilities and age-related neurodegeneration^[21].

Background

The study of Brainstem has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.